This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Neuren Pharmaceuticals Limited, Acadia Pharmaceuticals Inc.. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Cecilia Betti: Innovator in Pharmaceutical Compositions
Introduction
Cecilia Betti is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating neurodegenerative and neurodevelopmental disorders. With a total of 5 patents to her name, her work has had a substantial impact on medical science.
Latest Patents
Cecilia's latest patents include innovative formulations and methods related to trofinetide. One of her notable disclosures is the development of crystalline forms of trofinetide and trofinetide hydrate. This patent outlines pharmaceutical compositions that utilize these crystalline forms, along with methods for their production and application in treating various diseases. Another significant patent describes the manufacture of trofinetide and its side products, focusing on pharmaceutical uses to address neurodegenerative conditions.
Career Highlights
Throughout her career, Cecilia has worked with reputable companies in the pharmaceutical industry. Notably, she has been associated with Neuren Pharmaceuticals Limited and Acadia Pharmaceuticals Inc. Her expertise in the field has allowed her to contribute to groundbreaking research and development projects.
Collaborations
Cecilia has collaborated with several professionals in her field, including Martin Bernard, Catherine Bousmanne, and Clive Blower. These collaborations have further enhanced her research and innovation capabilities.
Conclusion
Cecilia Betti stands out as a dedicated inventor whose work in pharmaceutical compositions is paving the way for advancements in treating complex disorders. Her contributions continue to influence the medical field positively.